天津力生制药股份有限公司 2025年第二次临时股东会决议公告

Meeting Overview - The shareholder meeting was held on September 8, 2025, combining on-site and online voting methods [4][5][7] - The total share capital of the company as of the registration date was 257,704,999 shares, with 1,439,980 shares in the repurchase account not entitled to vote, resulting in 256,265,019 shares eligible for voting [5][6] Voting Results - No proposals were rejected during the meeting [1][2] - The controlling shareholder, Tianjin Jinhao Pharmaceutical Co., Ltd., abstained from voting on Proposal 1, with 131,194,851 shares involved [8] - Proposals 2, 5, and 6 were special resolutions that received over two-thirds approval from the voting shareholders and their authorized representatives [8] Legal Compliance - The meeting complied with relevant laws, regulations, and the company's articles of association, as confirmed by the legal opinions provided by Tianjin Sifang Junhui Law Firm [8][9]